Bevers S, Kooijmans SAA, Van de Velde E, Evers MJW, Seghers S, Gitz-Francois JJJM, van Kronenburg NCH, Fens MHAM, Mastrobattista E, Hassler L, Sork H, Lehto T, Ahmed KE, El Andaloussi S, Fiedler K, Breckpot K, Maes M, Van Hoorick D, Bastogne T, Schiffelers RM, De Koker S

Mol Ther. 2022 07 11;:

A state of the art in analytical quality-by-design and perspectives in characterization of nano-enabled medicinal products.

Bastogne T, Caputo F, Prina-Mello A, Borgos S, Barberi-Heyob M

J Pharm Biomed Anal. 2022 06 24;219:114911

Contribution of hemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.

Champéroux P, Fares R, Bastogne T, Richard S, Le Guennec JY, Thireau J

Br J Pharmacol. 2022 06 24;:

AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin.

Geoffroy M, Lemesle M, Kleinclauss A, Mazerbourg S, Batista L, Barberi-Heyob M, Bastogne T, Boireau W, Rouleau A, Dupommier D, Boisbrun M, Comoy C, Flament S, Grillier-Vuissoz I, Kuntz S

Int J Mol Sci. 2022 06 20;23(12):

Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.

Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S

Tumori. 2022 05 16;:3008916221078061

Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.

Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, Roux PE, Poupart M, Vogin G, Foray N, Pereira S

Cancers (Basel). 2021 May 19;13(10):

Transverse isotropic modelling of left-ventricle passive filling: Mechanical characterization for epicardial biomaterial manufacturing.

Jehl JP, Dan P, Voignier A, Tran N, Bastogne T, Maureira P, Cleymand F

J Mech Behav Biomed Mater. 2021 Apr 15;119:104492

A signal demodulation-based method for the early detection of Cheyne-Stokes respiration.

Guyot P, Djermoune EH, Chenuel B, Bastogne T

PLoS ONE. 2020 ;15(3):e0221191

Bridging communities in the field of nanomedicine.

Halamoda-Kenzaoui B, Baconnier S, Bastogne T, Bazile D, Boisseau P, Borchard G, Borgos SE, Calzolai L, Cederbrant K, Di Felice G, Di Francesco T, Dobrovolskaia MA, Gaspar R, Gracia B, Hackley VA, Leyens L, Liptrott N, Park M, Patri A, Roebben G, Roesslein M, Thürmer R, Urbán P, Zuang V, Bremer-Hoffmann S

Regul. Toxicol. Pharmacol.. 2019 Apr 30;:

The Phosphorylated ATM Immunofluorescence Assay: A High-performance Radiosensitivity Assay to Predict Postradiation Therapy Overreactions.

Vogin G, Bastogne T, Bodgi L, Gillet-Daubin J, Canet A, Pereira S, Foray N

Int. J. Radiat. Oncol. Biol. Phys.. 2018 Jul 1;101(3):690-693

A branching process model of heterogeneous DNA damages caused by radiotherapy in in vitro cell cultures.

Bastogne T, Marchand JL, Pinel S, Vallois P

Math Biosci. 2017 Dec;294:100-109

Quality-by-Design of Nano-Pharmaceuticals - A State of the Art.

Bastogne T

Nanomedicine. 2017 Jun;:

Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma.

Toussaint M, Pinel S, Auger F, Durieux N, Thomassin M, Thomas E, Moussaron A, Meng D, Plénat F, Amouroux M, Bastogne T, Frochot C, Tillement O, Lux F, Barberi-Heyob M

Theranostics. 2017 ;7(2):436-451